Cycurion is trading at $0.60, with a -10.05% change, as investors continue repricing dilution risk from its completed warrant-inducement financing.
- The deal raised approximately $4.5 million through exercise of 3,341,439 warrants and issued 5,012,159 new warrants, creating potential future dilution.
- Cycurion confirmed its Nasdaq hearing is scheduled for August 20, 2026; delisting action remains stayed, providing trading continuity but not removing listing uncertainty.